Optilite analyzer reagents

Background
The Department of Veterans Affairs, specifically the Southern Arizona Healthcare System, is seeking to establish a Blanket Purchase Agreement (BPA) for the acquisition of reagents and consumable test kits for use with the Optilite analyzer. This procurement aims to support the healthcare system's diverse patient population and enhance its diagnostic capabilities. The BPA will be awarded to a single contractor through a full and open competition, ensuring that the needs of the facility are met effectively.

Work Details
The contract includes the delivery of various Optilite analyzer reagents and consumables as specified below:

1. **Optilite Kfree Kit** - 120 units (MPN: LK016.OPT.A)
2. **Optilite Lambda Free Kit** - 120 units (MPN: LK018.OPT.A)
3. **Optilite Caeruloplasmin Kit** - 20 units (MPN: NK045.OPT.A)
4. **Optilite Diluent 1** - 32 units (MPN: IK709)
5. **Optilite Dilutent 2** - 7 units (MPN: IK710)
6. **Sample Cups (0.5ml)** - 10 units (MPN: IK704)
7. **Sample Cups (2ml)** - 10 units (MPN: IK705)
8. **Optilite Cuvettes TENCELL** - 10 units (MPN: IK702)
9. **Washing Solution (20ml)** - 10 units (MPN: IK703)
10. **Washing Solution (100ml)** - 10 units (MPN: IK704)
11. **Tubing Maintenance Solution (20ml)** - 4 units (MPN: IK705)

All reagents must be FDA approved and compatible with the Optilite analyzer, adhering to specific performance standards outlined in the Statement of Work.

Period of Performance
Base Period from November 9, 2026, to November 8, 2027, with four optional years extending until November 8, 2031.

Place of Performance
Department of Veterans Affairs Southern Arizona Healthcare System Tucson AZ 85923 UNITED STATES

Bidder Requirements
Bidders must provide FDA-approved reagents that are validated for use on the Optilite analyzer and must adhere to strict quality standards set by Binding Site Laboratories regarding product substitution and reuse.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity appears to have a confirmed incumbent based on prior award 36C26223A0029, awarded to Binding Site for $1,993,798 (03/13/23–03/12/28). The prior work involved providing FDA-validated reagents, consumables, and supplies for use at the VA Southern Arizona Healthcare System for reference testing specifically on the Optilite analyzer, with requirements tied to each reagent type. The current BPA similarly calls for Optilite analyzer reagents and consumable test kits (e.g., Optilite Kfree/Lambda Free/Caeruloplasmin kits and associated diluents, cups, cuvettes, and washing/tubing solutions), indicating a continuation of the same analyzer-specific supply support.